M&
Moelis & Co (MC)·Q2 2024 Earnings Summary
Executive Summary
- Q2 2024 revenue accelerated to $264.6M, up 45% YoY, with diluted EPS of $0.17 GAAP and $0.18 adjusted; the strength was broad-based across M&A, restructuring and capital markets, with capital markets posting its best quarter since Q1 2022 .
- Compensation was accrued at 75% and non-comp expenses were $46.6M, consistent with the firm’s plan pending better full-year visibility next quarter; underlying corporate tax rate remained 34% .
- Backlog and pipeline conversion improved notably versus Q1; management expects continued momentum as sponsor activity reengages and valuation rotations favor mid-market comps, citing faster conversion and rising activity levels .
- Dividend maintained at $0.60 per share; cash and liquid investments increased to $191.3M with no debt—supporting flexibility while revenue tailwinds build .
- Wall Street consensus (S&P Global) for Q2 2024 was unavailable due to data access limits; estimate comparison could not be performed (see Estimates Context).
What Went Well and What Went Wrong
-
What Went Well
- Broad-based momentum: “improved performance across each of our major product areas,” with public company strategic transactions a significant contributor; capital markets had best quarter since Q1 2022 .
- Backlog and conversion: pipeline activity “highest ever” outside SVB onboarding; conversion ratio and speed improved meaningfully by quarter-end versus Q1 .
- Private credit opportunity: hybrid/private capital in high demand—Moelis’ independent advisory positioning benefits from shoppers seeking bespoke financing across multiple private lenders .
-
What Went Wrong
- Elevated comp ratio persists: 75% accrual maintained pending better visibility; normalization requires sustained revenue recovery (management aims to reassess next quarter) .
- Share count creep: ~900k quarterly “unaffected amortization,” with buybacks paused—dilution pressure remains a consideration until repurchases resume .
- Pull-forward revenues: $6–$7M recognized in Q2; while supportive, it introduces some timing noise for trend analysis .
Financial Results
KPIs
- Cash & Liquid Investments ($USD Millions): Q1 2024 $124.9; Q2 2024 $191.3 .
- Dividend per Share: $0.60 declared in Q2; payable Sept 26, 2024 to holders of record Aug 5, 2024 .
- Other Income (GAAP): Q2 2023 -$5.6M vs Q2 2024 $1.7M (YoY improvement); Adjusted: $2.2M vs $2.7M .
- Pull-forward revenue recognized in Q2: ~$6–$7M .
- MD talent: YTD seven promotions and seven hires; three MDs added since last release in Tech, Industrials, Capital Structure Advisory .
Guidance Changes
Note: The company does not provide formal revenue/EPS guidance; management commentary above reflects operational parameters and capital return stance .
Earnings Call Themes & Trends
Management Commentary
- “Our results this quarter reflect improved performance across each of our major product areas… our capital markets business had its best quarter since the first quarter of 2022.” – Ken Moelis, CEO .
- “Our compensation expense was accrued at 75% consistent with last quarter… underlying corporate tax rate was 34%… noncompensation expenses were $46.6 million.” – Joe Simon, CFO .
- “By the end of this quarter… conversion ratio… is speeding up.” – Ken Moelis, on pipeline conversion .
- “Sponsors are moving back to the front… workload is high… momentum is there, and it’s real.” – Ken Moelis on PE activity .
Q&A Highlights
- Backlog and conversion velocity: Activity and conversion improved markedly from Q1; highest new business review activity levels ever (ex-SVB onboarding) .
- Regulatory outlook: A friendlier FTC following elections could unlock multiple stalled/abandoned deals; corporate tax policy clarity also matters for risk-taking .
- Mix and contribution: Restructuring plus capital markets ~30% of Q2 revenue; backlog in capital markets building given private credit demand .
- Cost/structure: Q2 comp ratio held at 75% pending visibility; share count amortization ~900k per quarter; pull-forward revenue ~$6–$7M .
- Macro catalysts: Rate cuts and valuation rotation into the Russell 2000/mid-market could accelerate sponsor exits and new investments .
Estimates Context
- S&P Global consensus estimates for Q2 2024 (EPS and revenue) were unavailable due to access limits; therefore, an estimates comparison could not be provided at this time. Values would typically be anchored to S&P Global consensus; in absence of access, we refrain from using non-S&P sources to avoid inconsistency.
Key Takeaways for Investors
- Revenue momentum is broadening beyond M&A as capital markets/private credit drive advisory demand; this reduces cyclicality and supports near-term upside as sponsor activity returns .
- Conversion velocity and backlog health improved versus Q1, suggesting a stronger 2H setup; watch for further acceleration and potential comp ratio normalization next quarter .
- Cost discipline remains key: 75% comp accrual and ~$46.6M non-comp in Q2 align with plan; sustained revenue recovery is the lever to expand margins toward long-term targets .
- Regulatory outcomes and rates are near-term catalysts; any FTC stance softening or stable rate backdrop should unlock larger deal flow, particularly for corporates and sponsors .
- Dividend continuity ($0.60) and rising cash ($191.3M) with no debt provide capital flexibility; buyback resumption could mitigate share creep once visibility improves .
- Product mix tailwinds: As restructuring transitions to funding solutions, Moelis can capture economics via capital markets—supporting revenue durability through cycles .
- Trading setup: With improving top-line, cleaner YoY comps (no SEC settlement drag), and visible private credit tailwinds, further beats hinge on conversion pace and sponsor follow-through; monitor Q3 comp ratio update and backlog commentary .
Citations: Q2 press release/8-K and tables ; Q2 earnings call transcript ; Q1 2024 press release ; Q1 and Q4 2023 calls .